Development of a novel method for early detection of pancreatic cancer

Important results from the project

** Denna text är maskinöversatt ** The aim of the project was to, through a collaboration between Reccan, Kirurgi Region Skåne and Lund University, develop a blood-based diagnostic test for the detection of pancreatic cancer in risk patients. Pancreatic cancer is considered to be the biggest challenge in the field of cancer as the disease is usually diagnosed late and there is a lack of simple available methods for early diagnosis. Clinical data has been generated, software for the interpretation of biomarker data has been developed and technical documentation has been prepared.

Expected long term effects

** Denna text är maskinöversatt ** The test is expected to be able to detect pancreatic cancer in patients who have an increased risk of developing it. This may be due to hereditary factors or a new-onset diabetes. Clinical data are being processed to guide further clinical studies

Approach and implementation

** Denna text är maskinöversatt ** The project has proceeded largely according to plan, but with some delay in the middle of the project to some extent depending on technical challenges but also on deliveries of raw materials. A close collaboration with Region Skånes surgeons and researchers from Lund University has been crucial to achieving success in the project.